Install
FirstWord
- 112articles · 30d
- 14+ hour agolatest article
- Aug 17, 2026earliest in window
- 0%with images
- 13avg words
- Medical 92
- Health 75
- Health & Wellness 68
- Business & Industrial 39
- Economy, Business & Finance 25
- Finance & Business 16
- Science & Technology 10
- News 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Spotlight On: Ivonescimab beats expectations to revive practice-changing hopes in NSCLC
14+ hour, 43+ min ago (13+ words) FirstWord Pharma...
WCLC26: Ivonescimab delivers 27% lower risk of death in Chinese NSCLC study
17+ hour, 38+ min ago (14+ words) FirstWord Pharma...
AbbVie aims to expand Qulipta's label into new migraine market
3+ day, 13+ hour ago (12+ words) FirstWord PHARMA...
Animal data trigger enrollment pause in Biohaven's epilepsy study
3+ day, 17+ hour ago (11+ words) FirstWord PHARMA...
Solstice raises $225M to advance next-gen CTLA-4 immunotherapy
4+ day, 19+ hour ago (10+ words) FirstWord Pharma...
Kura spins out Caspian to take menin inhibitor into diabetes
5+ day, 1+ hour ago (12+ words) FirstWord Pharma...
Shionogi's regeneration-inducing drug comes up short in acute ischemic stroke study
5+ day, 3+ hour ago (13+ words) FirstWord Pharma...
Inhibrx touts HNSCC subgroup data, eyes accelerated pathway for OX40 agonist
5+ day, 13+ hour ago (13+ words) FirstWord Pharma...
Physician Views Preview: How are prescribing patterns changing in COPD?
5+ day, 7+ hour ago (12+ words) FirstWord Pharma...
AstraZeneca's tozorakimab cuts COPD exacerbations by up to 34% in Phase III
5+ day, 22+ hour ago (14+ words) FirstWord Pharma...